DR.WU Skincare Co., Ltd.

DR.WU Skincare Co., Ltd.

TTPEX:6523
87.90
TWD
+0.40
(+0.46%)
6.61EPS
14.81P/E
4.41BMarket Cap
Mar 10Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
17.34
16.03
20.46
26.02
20.45
21.32
22.51
16.97
24.55
20.57
25.24
27.57
25.93
23.89
Basic EPS, GAAP
5.79
5.79
5.4
7.06
2.78
0.55
4.26
14.68
6.58
7.55
9.43
10.57
7.78
6.62
Free Cash Flow per Basic Share
4.8
4.03
3.85
6.04
1.3
2.46
4.52
6.64
6.46
7.2
8.64
9.64
7.44
8.21
Dividend per Share
2.4
2.73
4
1.91
6.6
2.5
0.45
13.86
17.22
8
10
11
10
8.01
Book Value per Share
11.3
21.22
22.6
44.74
40.85
37.98
41.82
44.37
34.07
33.94
32.73
32.3
30.08
28.28
Tangible Book Value per Share
11.26
21.16
22.56
44.69
40.71
37.82
41.71
44.3
34.07
33.94
32.71
32.29
30.07
28.27
Basic Weighted Avg Shares
33
41
42
44
46
45
45
45
45
45
45
45
45
45
Sales/Revenue/Turnover
565
663
865
1,151
937
963
1,014
765
1,106
927
1,137
1,242
1,168
1,075
Operating Margin (%)
39.18
37.59
30.63
33.26
15.27
7.42
24.04
31.03
34.04
40.2
43.09
42.27
36.56
28.45
Depreciation Expense
2
4
5
6
10
20
24
14
12
10
9
8
10
11
Net Income, GAAP
189
239
228
312
127
25
192
661
296
340
425
476
350
298
Effective Tax Rate (%)
17.82
18.38
16.48
16.74
14.15
60.73
15.95
16.64
20.37
19.83
19.22
20
20.66
19.69
Profit Margin (%)
33.37
36.1
26.4
27.13
13.58
2.58
18.91
86.46
26.78
36.68
37.35
38.35
29.98
27.71
Working Capital
467
877
924
2,005
1,784
1,634
1,797
1,885
1,412
1,400
1,336
1,016
963
975
LT Debt
- -
- -
- -
- -
- -
- -
34
25
16
6
- -
37
30
24
Total Equity
478
898
956
2,050
1,872
1,711
1,884
1,999
1,535
1,529
1,474
1,455
1,355
1,274
Return on Invested Capital (%)
48.31
28.37
23.07
20.75
6.19
1.54
10.81
9.69
15.96
18.75
25.17
26.94
22.71
17.09
Return on Capital (%)
54.35
34.78
24.65
20.77
6.49
1.39
10.59
33.44
16.52
21.93
28.1
32
24.25
21.52
Return on Common Equity (%)
53.25
34.79
24.65
20.77
6.49
1.39
10.67
34.06
16.77
22.19
28.28
32.52
24.93
22.06

Capital Structure

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
11
11
11
LT Borrowings
- -
- -
- -
LT Finance Leases
30
27
24
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
45
45
45
Market Capitalization
5,338
5,226
4,415

Working Capital

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
1,167
1,360
1,319
Cash, Cash Equivalents & STI
836
959
1,001
Accounts Receivable, Net
126
218
126
Inventories
169
148
165
Total Current Liabilities
205
304
344
Payables & Accruals
- -
- -
- -
ST Debt
11
11
11
Deferred Revenue
- -
- -
- -

Growth Rates

TWD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
7.8%
-7.07%
-6.89%
Free Cash Flow
22.04%
3.51%
-22.88%
Net Income, GAAP
78.4%
-5.96%
-26.45%
Sales/Revenue/Turnover
5.23%
10.89%
-5.92%
Total Cash Common Dividend
303.95%
-0.68%
-9.09%

Quarterly Revenue

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
349
246
304
343
1,242
2025
347
226
321
275
1,168
2026
276
203
- -
- -
- -

Quarterly Earnings Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
3.6
1.7
2.15
3.12
10.57
2025
3.44
-0.07
2.47
1.94
7.78
2026
1.88
0.32
- -
- -
- -

Quarterly Dividends Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
2
7
11
2025
- -
- -
2
6
10
2026
- -
- -
- -
- -
- -

Company Description

CEO
Yi Jui Wu
Full Time Employees
150
Sector
Consumer non-durables
Industry
Household/Personal care
Address
No.70, Nanjing East Road Taipei TP Taiwan 104
IPO Date
Jun 16, 2016
Website
drwu.com
Business
Dr. Wu Skincare Co., Ltd. (6523.TWO) develops, manufactures, and sells clinical skincare and cosmetics products primarily targeting sensitive and problem skin types in Taiwan and internationally. Founded in 2003 by dermatologist Dr. Ying-Chin Wu and his son Eric Wu and headquartered at No. 70 Section 3, Nanjing East Road, Zhongshan District, Taipei, Taiwan, the company offers hyaluronic acid moisturizing series; mandelic acid skin rejuvenating series; super anti-aging repair series; squalane plant extract repair series; translucent whitening series; laboratory essence series; super retinol rejuvenating series; capsule mask series; all-round sunscreen series; mineral flawless foundation series; beauty health food series; and readermx professional line, distributed through over 2,000 outlets including Watsons, SASA, Mannings, and e-commerce platforms such as Tmall, JD.com, Amazon, Lazada, and Shopee across Northeast Asia, Southeast Asia, and North America. The company listed on the Taipei Exchange's Emerging Stock Market in June 2016 following a minority investment from L Capital Asia, affiliated with LVMH Group, in 2014, and recently reported earnings for the second quarter and six months ended June 30, 2025, alongside the resignation of Chief Financial Officer Tina Lin effective June 30, 2025.